Not applicableUnknownNCT02187081What this trial is testingRadiofrequency Ablation Accompanied With Spontaneous Sorafenib in Early to Intermediate Stage HCCWho this might be right forHCC Southwest Hospital, China 380
Post-approval studies (Phase 4)Active Not RecruitingNCT06627530What this trial is testingCOACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcerWho this might be right forProstate Cancer Brazilian Clinical Research Institute 144
Not applicableNot Yet RecruitingNCT05928754What this trial is testingProspective CoHoRt Of Non-infectious Intermediate, pOsterior or panuveitiSWho this might be right forNon-infectious Uveitis Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 2,000
Large-scale testing (Phase 3)UnknownNCT00175396What this trial is testingAndrogen Suppression Combined With Elective Nodal and Dose Escalated Radiation TherapyWho this might be right forProstate Cancer University of British Columbia 400
Early research (Phase 1)Study completedNCT02710188What this trial is testingRelative Bioavailability Study in Healthy Subjects to Evaluate the Pharmacokinetics of HTL0009936 After One Dose of Prototype FormulationWho this might be right forAlzheimer's Disease Nxera Pharma UK Limited 14
Large-scale testing (Phase 3)Looking for participantsNCT07189169What this trial is testingQA108 Phase III Study in Subjects With Intermediate AMDWho this might be right forIntermediate Age-Related Macular Degeneration Smilebiotek Zhuhai Limited 400
Not applicableEnded earlyNCT01414712What this trial is testingCirculating Tumor Cells in Prostate Cancer PatientsWho this might be right forProstate Cancer University of Texas Southwestern Medical Center 2
Large-scale testing (Phase 3)Active Not RecruitingNCT03937219What this trial is testingStudy of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Exelixis 855
Large-scale testing (Phase 3)Active Not RecruitingNCT04055493What this trial is testingAdj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBCWho this might be right forBreast Cancer Female Women's Cancer Study Group GmbH 1,684
Post-approval studies (Phase 4)Looking for participantsNCT04642430What this trial is testingCOmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial FibrillationWho this might be right forAtrial Fibrillation Ottawa Hospital Research Institute 3,018
Not applicableStudy completedNCT03859492What this trial is testingScreening CEDM in Intermediate and High-Risk Patient PopulationsWho this might be right forBreast Cancer Mayo Clinic 461
Not applicableLooking for participantsNCT03417336What this trial is testingStudy Evaluating the Efficacy and the Tolerance of Pelvic-prostatic Hypo-fractionated Radiotherapy Followed by Boost in Patients With Prostate Adenocarcinoma Adverse Intermediate Risk or High Localized RiskWho this might be right forTo Evaluate the Rate of Digestive and Urinary Toxicity Centre Georges Francois Leclerc 90
Early research (Phase 1)Study completedNCT01375699What this trial is testingDoxorubicin With or Without Sildenafil, With Analysis of Cardiac MarkersWho this might be right forBreast CancerGastrointestinal CancerGenitourinary Cancer+2 more Virginia Commonwealth University 26
Not applicableStudy completedNCT00899912What this trial is testingChanges in DNA After Radiation Therapy in Patients With Prostate CancerWho this might be right forProstate Cancer Radiation Therapy Oncology Group 13
Not applicableEnded earlyNCT05070130What this trial is testingOpSens PRIME CLASSWho this might be right forAortic Stenosis Opsens, Inc. 32
Testing effectiveness (Phase 2)UnknownNCT06201507What this trial is testingBV-AVD-R Treatment Children Hodgkin's LymphomaWho this might be right forHodgkin Lymphoma Beijing Children's Hospital 44
Testing effectiveness (Phase 2)Ended earlyNCT02315625What this trial is testingStudy of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive SurgeryWho this might be right forNeuroendocrine TumorsNeuroendocrine CarcinomaNeuroendocrine Neoplasms+2 more National Cancer Institute (NCI) 16
Not applicableNot Yet RecruitingNCT06156033What this trial is testingPerioperative Smart Device Monitoring to Predict ComplicationsWho this might be right forPost-Op Complication Centre Hospitalier Universitaire Vaudois 50
Testing effectiveness (Phase 2)Looking for participantsNCT05346848What this trial is testingRandomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate CancerWho this might be right forProstate Cancer Institut Bergonié 62
Not applicableStudy completedNCT00105378What this trial is testingDutch EASYcare StudyWho this might be right forCognition DisordersMood DisorderGait Disorder, Neurologic+1 more Radboud University Medical Center 155